does glp 1 cause eye problems As the use of GLP-1 medications continues to rise, researchers are exploring their potential impact on health. While these drugs can help manage diabetes and promote weight loss, recent studies suggest GLP-1 Meds Reduce Risk of

Preclinical studies have confirmed that GIPRGLP1R coagonists improve several hallmarks of metabolic syndrome, such as obesity, hyperglycemia, and dyslipidemia

For individuals of Asian descent, a BMI Current Strategies in Managing Obesity Read More

Dizziness during semaglutide treatment often stems from rapid blood sugar drops, dehydration, or dose escalation

Leading Players in the GLP-1 Market Novo Nordisk 38.72% Ozempic Wegovy Rybelsus Eli Lilly 28.41% Mounjaro Zepbound Sanofi 8.76% 4 AstraZeneca 6.62% 5 GSK 4.95% 6 Regeneron 3.27% 7 Pfizer 2.61% 8 Amgen 1.98% 9 Sun Pharma 1.52% Boehringer Ingelheim 1.24% Together, Novo Nordisk and Eli Lilly account for more than 67% of the market, highlighting the intense competition between the two companies that currently lead the obesity and diabetes treatment revolution